Kazia Therapeutics Ltd ADR (KZIA) financial statements
Kazia Therapeutics Ltd ADR reported revenue of 42,000 AUD in fiscal 2025, down 22.3% a year over 9 years.
Net income was -21M AUD.
The diluted share count rose 28% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions (AUD).
Income statement
Fiscal years, in AUD, from Kazia Therapeutics Ltd ADR's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 406,000 AUD | 249,000 AUD | 119,000 AUD | — | — | 15M AUD | 0 AUD | 0 AUD | 2M AUD | 42,000 AUD |
| Research and development | 10M AUD | 11M AUD | 10M AUD | 6M AUD | 9M AUD | 15M AUD | 20M AUD | 16M AUD | 17M AUD | 7M AUD |
| Selling, general and admin | 6M AUD | 9M AUD | 6M AUD | 4M AUD | 4M AUD | 7M AUD | 5M AUD | 9M AUD | 14M AUD | 9M AUD |
| Interest expense | 0 AUD | 1,000 AUD | 0 AUD | — | — | — | — | — | — | — |
| Pre-tax income | -12M AUD | -11M AUD | -6M AUD | -11M AUD | -13M AUD | -9M AUD | -25M AUD | -21M AUD | -27M AUD | -22M AUD |
| Income tax | — | -199,000 AUD | -305,000 AUD | -298,000 AUD | -298,000 AUD | -484,000 AUD | -368,000 AUD | -271,000 AUD | -271,000 AUD | -2M AUD |
| Net income | -12M AUD | -11M AUD | -6M AUD | -10M AUD | -12M AUD | -8M AUD | -25M AUD | -20M AUD | -27M AUD | -21M AUD |
| EPS (diluted) | -2.82 AUD | -2.28 AUD | -12.48 AUD | -17.86 AUD | -0.17 AUD | -0.07 AUD | -0.19 AUD | -0.11 AUD | -0.10 AUD | -0.04 AUD |
| Diluted shares | 427M | 468M | 48M | 58M | 73M | 118M | 132M | 184M | 264M | 548M |
| Net margin | -2971.2% | -4285.1% | -5074.8% | — | — | -55.5% | — | — | -1160.2% | -49290.5% |
Balance sheet
Fiscal years, in AUD, from Kazia Therapeutics Ltd ADR's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | 33M AUD | 14M AUD | 6M AUD | 5M AUD | 9M AUD | 28M AUD | 7M AUD | 5M AUD | 2M AUD | 4M AUD |
| Receivables | — | 4M AUD | 3M AUD | 2M AUD | 1M AUD | 84,000 AUD | 91,000 AUD | 4M AUD | 4M AUD | 97,911 AUD |
| Total current assets | — | 19M AUD | 9M AUD | 8M AUD | 11M AUD | 29M AUD | 9M AUD | 11M AUD | 6M AUD | 5M AUD |
| Property, plant and equipment | 592,000 AUD | 490,000 AUD | 1,000 AUD | — | — | — | — | — | — | — |
| Total assets | — | 36M AUD | 28M AUD | 21M AUD | 23M AUD | 58M AUD | 36M AUD | 28M AUD | 22M AUD | 6M AUD |
| Total current liabilities | — | 5M AUD | 4M AUD | 2M AUD | 5M AUD | 8M AUD | 7M AUD | 8M AUD | 26M AUD | 14M AUD |
| Total liabilities | — | 11M AUD | 9M AUD | 7M AUD | 9M AUD | 20M AUD | 18M AUD | 16M AUD | 32M AUD | 14M AUD |
| Shareholders' equity | 34M AUD | 25M AUD | 19M AUD | 14M AUD | 14M AUD | 38M AUD | 18M AUD | 12M AUD | -10M AUD | -8M AUD |
| Net debt | -33M AUD | -14M AUD | -6M AUD | -5M AUD | -9M AUD | -28M AUD | -6M AUD | -3M AUD | -1M AUD | -4M AUD |
Cash flow
Fiscal years, in AUD, from Kazia Therapeutics Ltd ADR's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -12M AUD | -11M AUD | -9M AUD | -7M AUD | -9M AUD | -9M AUD | -23M AUD | -15M AUD | -10M AUD | -13M AUD |
| Capital spending | 525,000 AUD | 20,000 AUD | — | — | — | — | — | — | — | — |
| Free cash flow | -13M AUD | -11M AUD | — | — | — | — | — | — | — | — |
| Stock-based compensation | 372,000 AUD | 517,000 AUD | 165,000 AUD | 246,000 AUD | 262,000 AUD | 637,000 AUD | 2M AUD | 1M AUD | 533,000 AUD | 653,000 AUD |
| Dividends paid | — | 0 AUD | 0 AUD | 0 AUD | — | — | — | 0 AUD | 0 AUD | 0 AUD |
| Net borrowing | — | — | — | — | — | — | 0 AUD | 0 AUD | 405,000 AUD | 0 AUD |
| Free cash flow margin | -3080.0% | -4600.4% | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for KZIA.
Open KZIA in InvestinglyQuestions
What was Kazia Therapeutics Ltd ADR's revenue in 2025?
42,000 AUD in fiscal 2025, from its 10-K filing.
From Kazia Therapeutics Ltd ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.